Standard BioTools
LAB | NASDAQ
$0.62
-$0.09 (-12.36%)
At close: Nov 16, 2026, 4:00 PM ET
$0.60
-$0.02 (-3.06%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-12.36%
(1D)No price chart data available for 1D timeframe.
Rating
43.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #437/1021 (Top 43%)
Key Statistics
Market Data
Market Cap $245.16M
1D Range
0.60 0.71
52W Range
0.60 1.68
Valuation (TTM)
PE -5.64
PB 0.44
EV/EBITDA 2.31
Valuation (NTM)
Forward PE N/A
Forward PEG 0.12
Price Target $3.25
Cash Flow
FCF Yield -26.8%
SBC Adj. FCF Yield -35.9%
SBC Impact -34.0%
Margins
Gross Margin 50.8%
Operating Margin -90.6%
FCF Margin -77.8%
Growth (CAGR)
Revenue 3Y | 5Y -7.1% |
-9.2%
Dil EPS 3Y | 5Y 77.6% |
56.6%
FCF 3Y | 5Y 39.8% |
-1.8%
Returns
ROA -6.2%
ROE -7.5%
ROIC -6.6%
Financial Health
Net Cash
$434.28M
Current Ratio 9.75
Interest Coverage -15,299.20
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop ther...
Sector Healthcare
Industry Medical - Specialties
Employees 387
IPO Date Feb 10, 2011
Website www.standardbio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 3, 2026
EPS
$0.03
Beat +250.00%
YoY:
+133.33% REV
$19.39M
Beat +3.11%
YoY:
-0.85%Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove LAB